Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1993 Oct;110(2):645–650. doi: 10.1111/j.1476-5381.1993.tb13860.x

Partial agonist effect of the platelet-activating factor receptor antagonists, WEB 2086 and WEB 2170, in the rat perfused heart.

W Hu 1, I K McNicholl 1, P C Choy 1, R Y Man 1
PMCID: PMC2175904  PMID: 8242237

Abstract

1. WEB 2086 and WEB 2170 are potent platelet-activating factor (PAF) receptor antagonists and have been used widely as pharmacological tools to investigate the actions of PAF in a variety of biological systems. 2. Low concentrations of WEB 2086 and WEB 2170 blocked the vasoconstrictor action of PAF in the rat perfused heart. In this study, we observed that moderate concentrations of WEB 2086 and WEB 2170 increased the perfusion pressure in rat isolated hearts under constant flow perfusion. The vasoconstrictor actions of WEB 2086 and WEB 2170 were not observed with a structurally different PAF receptor antagonist, FR-900452. 3. To determine whether this vasoconstrictor action of WEB 2086 involved non-specific effects or was via the activation of PAF receptors, hearts were pretreated with 1000 pmol PAF or 50 microM FR-900452. These pretreatments attenuated the vasoconstrictor action of 1 microM WEB 2086, suggesting that the action of WEB 2086 may be mediated via PAF receptors. Pretreatment with the leukotriene receptor antagonist (L-649,923, 5 microM) and the leukotriene synthesis inhibitor (MK-886, 10 microM) that are known to block the vasoconstrictor action of PAF receptor activation also attenuated the vasoconstrictor action of WEB 2086. Pretreatment with PAF or MK-886 attenuated the vasoconstrictor action of 0.5 microM WEB 2170. 4. When PAF receptors were activated by PAF in the perfused heart, significant amounts of leukotriene C4 and leukotriene C4/D4/E4 were detected in the coronary effluent. However, no significant amount of these leukotrienes was detected in the coronary effluent when hearts were perfused with 1 microM WEB 2086 or 0.5 microM WEB 2170.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
645

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Braquet P., Touqui L., Shen T. Y., Vargaftig B. B. Perspectives in platelet-activating factor research. Pharmacol Rev. 1987 Jun;39(2):97–145. [PubMed] [Google Scholar]
  2. Gillard J., Ford-Hutchinson A. W., Chan C., Charleson S., Denis D., Foster A., Fortin R., Leger S., McFarlane C. S., Morton H. L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2 - dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor. Can J Physiol Pharmacol. 1989 May;67(5):456–464. doi: 10.1139/y89-073. [DOI] [PubMed] [Google Scholar]
  3. Grigoriadis G., Stewart A. G. 1-O-hexadecyl-2-acetyl-sn-glycero-3-phospho (N,N,N trimethyl) hexanolamine: an analogue of platelet-activating factor with partial agonist activity. Br J Pharmacol. 1991 Sep;104(1):171–177. doi: 10.1111/j.1476-5381.1991.tb12403.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Honda Z., Nakamura M., Miki I., Minami M., Watanabe T., Seyama Y., Okado H., Toh H., Ito K., Miyamoto T. Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung. Nature. 1991 Jan 24;349(6307):342–346. doi: 10.1038/349342a0. [DOI] [PubMed] [Google Scholar]
  5. Hu W. M., Choy P. C., Man R. Y. Characterization of the coronary vascular responses to platelet-activating factor in the isolated perfused heart. Lipids. 1991 Sep;26(9):700–704. doi: 10.1007/BF02535617. [DOI] [PubMed] [Google Scholar]
  6. Hu W. M., Man R. Y. Differential actions of platelet-activating factor (PAF) receptor antagonists on the vasodilator and vasoconstrictor effects of PAF in the rat perfused heart. Br J Pharmacol. 1991 Dec;104(4):773–775. doi: 10.1111/j.1476-5381.1991.tb12504.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hu W. M., Man R. Y. Interaction of vasoactive substances released by platelet-activating factor in the rat perfused heart. Br J Pharmacol. 1991 Dec;104(4):933–937. doi: 10.1111/j.1476-5381.1991.tb12529.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hu W., Kinnaird A. A., Man R. Y. Mechanisms of the coronary vascular effects of platelet-activating factor in the rat perfused heart. Br J Pharmacol. 1991 May;103(1):1097–1102. doi: 10.1111/j.1476-5381.1991.tb12306.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hwang S. B. Identification of a second putative receptor of platelet-activating factor from human polymorphonuclear leukocytes. J Biol Chem. 1988 Mar 5;263(7):3225–3233. [PubMed] [Google Scholar]
  10. Hwang S. B., Lee C. S., Cheah M. J., Shen T. Y. Specific receptor sites for 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) on rabbit platelet and guinea pig smooth muscle membranes. Biochemistry. 1983 Sep 27;22(20):4756–4763. doi: 10.1021/bi00289a022. [DOI] [PubMed] [Google Scholar]
  11. Jones T. R., Young R., Champion E., Charette L., Denis D., Ford-Hutchinson A. W., Frenette R., Gauthier J. Y., Guindon Y., Kakushima M. L-649,923, sodium (beta S*, gamma R*)-4-(3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propylthio)- gamma-hydroxy-beta-methylbenzenebutanoate, a selective, orally active leukotriene receptor antagonist. Can J Physiol Pharmacol. 1986 Aug;64(8):1068–1075. doi: 10.1139/y86-183. [DOI] [PubMed] [Google Scholar]
  12. Kroegel C., Yukawa T., Westwick J., Barnes P. J. Evidence for two platelet activating factor receptors on eosinophils: dissociation between PAF-induced intracellular calcium mobilization degranulation and superoxides anion generation in eosinophils. Biochem Biophys Res Commun. 1989 Jul 14;162(1):511–521. doi: 10.1016/0006-291x(89)92027-5. [DOI] [PubMed] [Google Scholar]
  13. Lambrecht G., Parnham M. J. Kadsurenone distinguishes between different platelet activating factor receptor subtypes on macrophages and polymorphonuclear leucocytes. Br J Pharmacol. 1986 Feb;87(2):287–289. doi: 10.1111/j.1476-5381.1986.tb10816.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Man R. Y., Hu W., Kinnaird A. A. Coronary vascular response to platelet-activating factor in the perfused rat heart. J Lipid Mediat. 1990 Mar-Apr;2(2):75–83. [PubMed] [Google Scholar]
  15. Okamoto M., Yoshida K., Nishikawa M., Ando T., Iwami M., Kohsaka M., Aoki H. FR-900452, a specific antagonist of platelet activating factor (PAF) produced by Streptomyces phaeofaciens. I. Taxonomy, fermentation, isolation, and physico-chemical and biological characteristics. J Antibiot (Tokyo) 1986 Feb;39(2):198–204. doi: 10.7164/antibiotics.39.198. [DOI] [PubMed] [Google Scholar]
  16. Piper P. J., Stewart A. G. Antagonism of vasoconstriction induced by platelet-activating factor in guinea-pig perfused hearts by selective platelet-activating factor receptor antagonists. Br J Pharmacol. 1987 Apr;90(4):771–783. doi: 10.1111/j.1476-5381.1987.tb11231.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Piper P. J., Stewart A. G. Coronary vasoconstriction in the rat, isolated perfused heart induced by platelet-activating factor is mediated by leukotriene C4. Br J Pharmacol. 1986 Jul;88(3):595–605. doi: 10.1111/j.1476-5381.1986.tb10240.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Saunders R. N., Handley D. A. Platelet-activating factor antagonists. Annu Rev Pharmacol Toxicol. 1987;27:237–255. doi: 10.1146/annurev.pa.27.040187.001321. [DOI] [PubMed] [Google Scholar]
  19. Stewart A. G., Dusting G. J. Characterization of receptors for platelet-activating factor on platelets, polymorphonuclear leukocytes and macrophages. Br J Pharmacol. 1988 Aug;94(4):1225–1233. doi: 10.1111/j.1476-5381.1988.tb11642.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Tokumura A., Homma H., Hanahan D. J. Structural analogs of alkylacetylglycerophosphocholine inhibitory behavior on platelet activation. J Biol Chem. 1985 Oct 15;260(23):12710–12714. [PubMed] [Google Scholar]
  21. Valone F. H., Coles E., Reinhold V. R., Goetzl E. J. Specific binding of phospholipid platelet-activating factor by human platelets. J Immunol. 1982 Oct;129(4):1637–1641. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES